PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
0.64%
Net income growth under 50% of MRVL's 52.30%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
4.72%
D&A growth well above MRVL's 2.78%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
163.22%
Deferred tax of 163.22% while MRVL is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
No Data
No Data available this quarter, please select a different quarter.
840.00%
Well above MRVL's 17.62% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
2.33%
Some inventory rise while MRVL is negative at -199.63%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
No Data
No Data available this quarter, please select a different quarter.
375.64%
Growth well above MRVL's 131.54%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
179.59%
Growth of 179.59% while MRVL is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might reflect intangible expansions or partial write-offs.
83.07%
Operating cash flow growth above 1.5x MRVL's 36.49%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-75.10%
Both yoy lines negative, with MRVL at -51.22%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
-726.77%
Negative yoy purchasing while MRVL stands at 69.14%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-0.50%
We reduce yoy sales while MRVL is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
100.00%
Less 'other investing' outflow yoy vs. MRVL's 14843.75%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
-304.19%
We reduce yoy invests while MRVL stands at 58.67%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
No Data
No Data available this quarter, please select a different quarter.
37.93%
Stock issuance far above MRVL's 14.07%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
61.61%
Buyback growth of 61.61% while MRVL is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.